Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 7,949,420 | 7,011,383 | 5,335,750 | 4,230,045 | 3,026,139 |
| Cost of Goods | 1,869,876 | 1,595,558 | 1,127,246 | 768,771 | 433,320 |
| Gross Profit | 6,079,544 | 5,415,825 | 4,208,504 | 3,461,274 | 2,592,819 |
| Operating Expenses | 2,118,198 | 1,887,162 | 1,530,209 | 1,297,538 | 3,351,892 |
| Operating Income | 3,962,222 | 3,529,221 | 2,678,541 | 2,164,507 | -758,753 |
| Interest Expense | 108,961 | 69,662 | 65,244 | 63,181 | 20,362 |
| Other Income | 60,287 | 42,397 | 59,401 | 109,823 | 140,908 |
| Pre-tax Income | 3,913,548 | 3,501,956 | 2,672,698 | 2,211,149 | -638,207 |
| Income Tax | 1,023,799 | 876,364 | 702,363 | 635,355 | 551,750 |
| Net Income Continuous | 2,889,749 | 2,625,592 | 1,970,335 | 1,575,794 | -1,189,957 |
| Minority Interests | -11,508 | -10,163 | -8,564 | -9,108 | N/A |
| Net Income | $2,901,257 | $2,635,755 | $1,978,899 | $1,584,902 | $-1,189,957 |
| EPS Basic Total Ops | 1.69 | 1.46 | 1.08 | 0.86 | -0.65 |
| EPS Basic Continuous Ops | 1.69 | 1.45 | 1.07 | 0.85 | -0.65 |
| EPS Diluted Total Ops | 1.66 | 1.41 | 1.03 | 0.82 | -0.65 |
| EPS Diluted Continuous Ops | 1.65 | 1.41 | 1.03 | 0.82 | -0.65 |
| EBITDA(a) | $4,227,699 | $3,742,165 | $2,834,151 | $2,265,867 | $-711,469 |